rs2018736

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_006329.4(FBLN5):​c.380-11587G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.468 in 152,118 control chromosomes in the GnomAD database, including 17,821 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.47 ( 17821 hom., cov: 33)

Consequence

FBLN5
NM_006329.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0110

Publications

12 publications found
Variant links:
Genes affected
FBLN5 (HGNC:3602): (fibulin 5) The protein encoded by this gene is a secreted, extracellular matrix protein containing an Arg-Gly-Asp (RGD) motif and calcium-binding EGF-like domains. It promotes adhesion of endothelial cells through interaction of integrins and the RGD motif. It is prominently expressed in developing arteries but less so in adult vessels. However, its expression is reinduced in balloon-injured vessels and atherosclerotic lesions, notably in intimal vascular smooth muscle cells and endothelial cells. Therefore, the protein encoded by this gene may play a role in vascular development and remodeling. Defects in this gene are a cause of autosomal dominant cutis laxa, autosomal recessive cutis laxa type I (CL type I), and age-related macular degeneration type 3 (ARMD3). [provided by RefSeq, Jul 2008]
FBLN5 Gene-Disease associations (from GenCC):
  • cutis laxa, autosomal dominant 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
  • cutis laxa, autosomal recessive, type 1A
    Inheritance: SD, AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • Charcot-Marie-Tooth disease, demyelinating, IIA 1H
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • demyelinating hereditary motor and sensory neuropathy
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • macular degeneration, age-related, 3
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • autosomal dominant cutis laxa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary sensorimotor neuropathy with hyperelastic skin
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive cutis laxa type 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.631 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FBLN5NM_006329.4 linkc.380-11587G>T intron_variant Intron 4 of 10 ENST00000342058.9 NP_006320.2 Q9UBX5A0A024R6G3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FBLN5ENST00000342058.9 linkc.380-11587G>T intron_variant Intron 4 of 10 1 NM_006329.4 ENSP00000345008.4 Q9UBX5

Frequencies

GnomAD3 genomes
AF:
0.468
AC:
71101
AN:
152000
Hom.:
17808
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.304
Gnomad AMI
AF:
0.322
Gnomad AMR
AF:
0.641
Gnomad ASJ
AF:
0.438
Gnomad EAS
AF:
0.527
Gnomad SAS
AF:
0.462
Gnomad FIN
AF:
0.518
Gnomad MID
AF:
0.320
Gnomad NFE
AF:
0.521
Gnomad OTH
AF:
0.475
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.468
AC:
71146
AN:
152118
Hom.:
17821
Cov.:
33
AF XY:
0.469
AC XY:
34855
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.303
AC:
12594
AN:
41506
American (AMR)
AF:
0.641
AC:
9809
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.438
AC:
1519
AN:
3472
East Asian (EAS)
AF:
0.527
AC:
2716
AN:
5158
South Asian (SAS)
AF:
0.464
AC:
2228
AN:
4806
European-Finnish (FIN)
AF:
0.518
AC:
5474
AN:
10568
Middle Eastern (MID)
AF:
0.330
AC:
97
AN:
294
European-Non Finnish (NFE)
AF:
0.521
AC:
35411
AN:
67988
Other (OTH)
AF:
0.475
AC:
1004
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1898
3796
5695
7593
9491
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
640
1280
1920
2560
3200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.506
Hom.:
77151
Bravo
AF:
0.467
Asia WGS
AF:
0.487
AC:
1696
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
2.1
DANN
Benign
0.70
PhyloP100
-0.011
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2018736; hg19: chr14-92373003; API